Cryo Cell International (CCEL) Operating Leases (2020 - 2026)

Cryo Cell International has disclosed Operating Leases across 7 years of filings, most recently posting $368941.0 for Q1 2026.

• In Q1 2026, Operating Leases fell 4.62% year-over-year to $368941.0; the TTM figure through Feb 2026 stood at $368941.0 (down 4.62% YoY), while the FY2025 annual figure was $474628.0, down 6.02% from the prior year.
• Operating Leases slipped to $368941.0 in Q1 2026, from $474628.0 in the prior quarter.
• Over the last five years, Operating Leases for CCEL reached as high as $967116.0 in Q2 2023 and fell as low as $242039.0 in Q1 2023.
• The 5-year median for Operating Leases is $505053.0 (2024), against an average of $546557.8.
• Annual changes were most pronounced in 2024 — Operating Leases jumped 217.7% — and 2025, when it plunged 60.56%.
• A 5-year view of Operating Leases shows it stood at $313298.0 in 2022, then soared by 171.93% to $851938.0 in 2023, then tumbled by 40.72% to $505053.0 in 2024, then declined by 6.02% to $474628.0 in 2025, then dropped by 22.27% to $368941.0 in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $368941.0, $474628.0, and $577202.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.